Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1444667802
总结
CYP2C19 *1/*2 + *1/*3 (assigned as intermediate metabolizers phenotype) are associated with increased risk of Cardiovascular Diseases when treated with clopidogrel as compared to CYP2C19 *1/*1 (assigned as normal metabolizer phenotype) .